Lung Cancer Non-Small Cell Cancer (NSCLC) Unknown Status Phase 2 Trials for Gefitinib (DB00317)

Also known as: Non - Small Cell Lung Cancer NSCLC / Carcinoma, Non-Small-Cell Lung / Non-Small-Cell Lung Carcinoma (NSCLC) / Non-Small-Cell Lung Carcinoma / Nonsmall Cell Lung Cancer / Lung Cancer(NSCLC) / Non-Small Cell Lung Cancer / Non-Small-Cell Lung Cancer (NSCLC) / NSCLC (Non-Small Cell Lung Cancer) / Non Small Cell Lung Cancer (NSCLC) / Lung Cancer (Non-Small Cell) / NSCLC, Non Small Cell Lung Cancer / Non-small Cell Lung Cancers / Lung Cancer, Nonsmall Cell / Non-Small Cell Lung Carcinoma / Lung Cancer Non-Small Cell / Non-Small-Cell Lung Cancer / Non-Small Cell Lung Cancer (NSCLC) / Non Small Cell Lung Cancer / Non-Small Cell Lung Carcinoma (NSCLC) / Carcinoma, Non-Small Cell Lung / Lung Cancer, Non-Small Cell / Non Small-cell Lung Cancer / NSCLC Non-small Cell Lung Cancer / NSCLC / Non Small Cells Lung Cancer / Non-Small Cell Lung Cancer(NSCLC) / Non- Small Cell Lung Cancer / Lung Cancer - Non Small Cell / Lung Cancer (NSCLC) / Non Small Cell Lung Cancer NSCLC / Non-Small-Cell-Lung Cancer (NSCLC) / Non-Small-Cell-Lung Cancer / Non-small cell lung cancer (disorder) / Non-small cell lung cancer NOS

IndicationStatusPhase
DBCOND0046916 (Lung Cancer Non-Small Cell Cancer (NSCLC))Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02319577GEfitinib Plus viNOrelbine in Advanced EGFR Mutated NSCLC. GENOA TrialTreatment
NCT01833572Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLCTreatment
NCT01784549Customized Neoadjuvant Versus Standard Chemotherapy in NSCL Patients With Resectable Stage IIIA (N2)DiseaseTreatment
NCT01755923Gefitinib or Docetaxel as Second Line Therapy for Wild-type Epidermal Growth Factor Receptor (EGFR) NSCLCTreatment
NCT01746277Study of Chemotherapy Sequenced by or Combined With EGFR-TKIs for NSCLC Patients Failed to EGFR-TKIs TherapyTreatment
NCT01510990First Line Gefitinib by FDG-PET Metabolic ResponseTreatment
NCT01502202Intercalated Administration of PamCis With Gefitinib or Placebo as First Line Lung Adenocarcinoma in Never SmokersTreatment
NCT01192243Study of Gefitinib Compared With Pemetrexed/Cisplatin in Advanced Non-Small Cell Lung Cancer PatientsTreatment
NCT00614809Efficacy of Gefitinib for Brain Metastasis of Non-Small Cell Lung CancerTreatment
NCT00319800Second-Line Irinotecan or Gefitinib in Docetaxel Pretreated NSCLCTreatment
NCT01312337Iressa for EGFR Mutation Negative Non-small Cell Lung Cancer (NSCLC)Treatment